Home › Funds › Octagon Capital Advisors LP › KYMR
Octagon Capital Advisors LP position in KYMR
KYMERA THERAPEUTICS INC · Health Care
Octagon Capital Advisors LP reported holding 205,000 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$22.9M, representing 3.05% of its reported portfolio and ranking #8 among its reported holdings. Octagon Capital Advisors LP has disclosed KYMR holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Octagon Capital Advisors LP's KYMR position evolved
Octagon Capital Advisors LP first disclosed a stake in KYMR in Q2 2025 at 266,000 shares (US$11.6M). The position peaked in Q4 2025 at 535,000 shares, worth US$41.6M. Across 6 filings, Octagon Capital Advisors LP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 205,000 shares valued at US$22.9M — a reduction of -105,000 shares quarter over quarter.. Notable position changes include a 35% increase in Q3 2025 (shares rose 37% over the following quarter), a 49% increase in Q4 2025 (shares rose 7% over the following quarter), a 34% trim in Q3 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 266.00K | $11.61M | New |
| Q3 2025 | 360.00K | $20.38M | Add |
| Q4 2025 | 535.00K | $41.63M | Add |
| Q1 2026 | 425.00K | $35.40M | Reduce |
| Q2 2026 | 310.00K | $35.55M | Reduce |
| Q3 2026 | 205.00K | $22.92M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYMR and 13F data
KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 49 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$967.8M), Avoro Capital Advisors LLC (US$835.6M), BVF INC/IL (US$432.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYMR
- BAKER BROS. ADVISORS LP 8.66M sh · $967.79M · Q3 2026
- Avoro Capital Advisors LLC 7.47M sh · $835.60M · Q3 2026
- BVF INC/IL 3.87M sh · $432.86M · Q3 2026
- Atlas Venture Life Science Advisors, LLC 2.85M sh · $318.33M · Q3 2026
- Siren, L.L.C. 2.78M sh · $311.32M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 808.10K sh · $90.34M · Q3 2026
- Merck & Co., Inc. 772.16K sh · $86.32M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 564.13K sh · $63.06M · Q3 2026
- Boxer Capital Management, LLC 524.55K sh · $58.64M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 490.61K sh · $54.84M · Q3 2026
- Rock Springs Capital Management LP 409.63K sh · $45.79M · Q3 2026
- BRAIDWELL LP 300.57K sh · $33.60M · Q3 2026
More on Octagon Capital Advisors LP
FAQ
How long has Octagon Capital Advisors LP held KYMR?
Octagon Capital Advisors LP has disclosed KYMR holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Octagon Capital Advisors LP's current position in KYMR?
As of Q3 2026, Octagon Capital Advisors LP holds 205.00K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $22.92M, representing 3.05% of its reported portfolio and ranking #8.
Has Octagon Capital Advisors LP been buying or selling KYMR?
In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP reduced its position in KYMR. The position peaked in Q4 2025 at 535.00K shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, BVF INC/IL, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.